143 related articles for article (PubMed ID: 17539620)
1. Novel ergopeptides as dual ligands for adenosine and dopamine receptors.
Vendrell M; Angulo E; Casadó V; Lluis C; Franco R; Albericio F; Royo M
J Med Chem; 2007 Jun; 50(13):3062-9. PubMed ID: 17539620
[TBL] [Abstract][Full Text] [Related]
2. 1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands.
Huber D; Hübner H; Gmeiner P
J Med Chem; 2009 Nov; 52(21):6860-70. PubMed ID: 19807103
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor ligands. Part VII [1]: novel 3-substituted 5-phenyl-1, 2, 3, 4, 5, 6-hexahydro-azepino-[4, 5-b]indoles as ligands for the dopamine receptors.
Decker M; Lehmann J
Arch Pharm (Weinheim); 2003 Oct; 336(10):466-76. PubMed ID: 14582123
[TBL] [Abstract][Full Text] [Related]
4. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
Bettinetti L; Löber S; Hübner H; Gmeiner P
J Comb Chem; 2005; 7(2):309-16. PubMed ID: 15762761
[TBL] [Abstract][Full Text] [Related]
5. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
[TBL] [Abstract][Full Text] [Related]
6. The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects.
Boeckler F; Gmeiner P
Pharmacol Ther; 2006 Oct; 112(1):281-333. PubMed ID: 16905195
[TBL] [Abstract][Full Text] [Related]
7. [The regulating effects of dopamine receptors on the level of adenosine 3, 5-cyclic monophosphate in bovine trabecular cells in vitro].
Lu Y; Li M
Zhonghua Yan Ke Za Zhi; 1998 Sep; 34(5):379-81. PubMed ID: 11877232
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists.
Robaa D; Enzensperger C; Abul Azm Sel D; El Khawass el S; El Sayed O; Lehmann J
J Med Chem; 2010 Mar; 53(6):2646-50. PubMed ID: 20180564
[TBL] [Abstract][Full Text] [Related]
9. GPCR targeted library design: novel dopamine D3 receptor ligands.
Böcker A; Sasse BC; Nietert M; Stark H; Schneider G
ChemMedChem; 2007 Jul; 2(7):1000-5. PubMed ID: 17477344
[No Abstract] [Full Text] [Related]
10. Synthesis, dopaminergic profile, and molecular dynamics calculations of N-aralkyl substituted 2-aminoindans.
Andujar SA; de Angel BM; Charris JE; Israel A; Suárez-Roca H; López SE; Garrido MR; Cabrera EV; Visbal G; Rosales C; Suvire FD; Enriz RD; Angel-Guío JE
Bioorg Med Chem; 2008 Mar; 16(6):3233-44. PubMed ID: 18166467
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of dual acting ligands targeting the adenosine A2A and dopamine D2 receptors for the potential treatment of Parkinson's disease.
Jörg M; May LT; Mak FS; Lee KC; Miller ND; Scammells PJ; Capuano B
J Med Chem; 2015 Jan; 58(2):718-38. PubMed ID: 25490054
[TBL] [Abstract][Full Text] [Related]
12. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response.
Fliri AF; Loging WT; Thadeio PF; Volkmann RA
J Med Chem; 2005 Nov; 48(22):6918-25. PubMed ID: 16250650
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO
Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964
[TBL] [Abstract][Full Text] [Related]
14. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
[TBL] [Abstract][Full Text] [Related]
16. Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].
Liu D; Wikström HV; Dijkstra D; de Vries JB; Venhuis BJ
J Med Chem; 2006 Feb; 49(4):1494-8. PubMed ID: 16480286
[TBL] [Abstract][Full Text] [Related]
17. A novel non-phenolic dibenzazecine derivative with nanomolar affinities for dopamine receptors.
Robaa D; Eldin AbulAzm S; Lehmann J; Enzensperger C
Chem Biodivers; 2011 Mar; 8(3):431-9. PubMed ID: 21404426
[TBL] [Abstract][Full Text] [Related]
18. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
[TBL] [Abstract][Full Text] [Related]
19. Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.
Fuxe K; Strömberg I; Popoli P; Rimondini-Giorgini R; Torvinen M; Ogren SO; Franco R; Agnati LF; Ferré S
Adv Neurol; 2001; 86():345-53. PubMed ID: 11553995
[No Abstract] [Full Text] [Related]
20. [Novel central dopaminergic agents derived from atypical di-substituted 2-aminoindane-4, 7. Synthesis and central pharmacological profile].
Ferrer-Mavárez RE; Urdaneta-Gutierrez NC; Porta-Knabenschuh N; Rodríguez-Villasmil LC; Rosales-Peña CC; Espinoza GA; Angel-Migliore LB; Balza-Jiménez Kdel C; Perdomo-Zavarce LE; Faría-Quintero AR; Dabian-Makarem AS; Zapata-Cárdenas MV; Linero-Arrieta AR; Acurero-Castellano GA; Israel-Stern A; Rosario Garrido M; Suárez-Roca H; Migliore de Angel Bdel C; Lopez-D'Sola SE; Charris-Charris J; Ramírez-Moran MM; Angel-Guío JE
Invest Clin; 2015 Jun; 56(2):137-54. PubMed ID: 26299055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
